Genetic polymorphisms in the growth hormone rexeptor: Impact on growth response and disease susceptibility

Current Pharmacogenomics and Personalized Medicine

Volumn 6, Issue 4, 2008, Pages 295-301

  Ihara, K ^a   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Grow hormone receptor; Growth hormone; Polymorphism

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOLEUCINE; JANUS KINASE 2; LEUCINE; PROLACTIN RECEPTOR; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; STAT PROTEIN;

BODY HEIGHT; BONE DENSITY; BREAST CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; GENE DELETION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; HUMAN; IDIOPATHIC SCOLIOSIS; LARON SYNDROME; REVIEW; SHORT STATURE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; TURNER SYNDROME;

EID: 67649306620     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569208786733875     Document Type: Review

References (63)

1. Adamafio, N. A. and Ng, F. M. (1984) Effects of growth hormone on lipo-genesis and glucose oxidation in genetically GH-deficient mice. Mol. Cell. Endocrinol. 37, 241-244.
2. Barton, D. E.; Foellmer, B. E.; Wood, W. I. and Francke, U. (1989) Chromosome mapping of the growth hormone receptor gene in man and mouse. Cytogenet. Cell. Genet. 50, 137-141.
3. Baumann, G. (2001) Growth hormone binding protein 2001. J. Pediatr. Endocrinol. Metab. 14, 355-375.
4. Bernasconi, A.; Marino, R.; Ribas, A.; Rossi, J.; Ciaccio, M.; Oleastro, M.; Ornani, A.; Paz, R.; Rivarola, M. A.; Zelazko, M. and Belgorosky, A. (2006) Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 118, e1584-1592.
5. Binder, G.; Baur, F.; Schweizer, R. and Ranke, M. B. (2006) The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-forgestational-age children. J. Clin. Endocrinol. Metab. 91, 659-664.
6. Blum, W.; Makinis, K.; Shavrikova, E.; Stobbe, H.; Pfaffle, R. and Amselem, S. (2005) The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the exon 3-minus isoform of the GH receptor (GHR). Horm. Res. 64(Suppl 1), 20.
7. Cameron, C. M.; Kostyo, J. L.; Adamafio, N. A.; Brostedt, P.; Roos, P.; Skottner, A.; Forsman, A.; Fryklund, L. and Skoog, B. (1988) The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action. Endocrinology 122, 471-474.
8. Carrascosa, A.; Esteban, C.; Espadero, R.; Fernandez-Cancio, M.; Andaluz, P.; Clemente, M.; Audi, L.; Wollmann, H.; Fryklund, L. and Parodi, L. (2006) The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. J. Clin. Endocrinol. Metab. 91, 3281-3286.
9. Carrascosa, A.; Audí, L.; Fernández-Cancio, M.; Esteban, C.; Andaluz, P.; Vilaró, E.; Clemente, M.; Yeste, D.; Albisu, M. A. and Gussinyé, M. (2008) The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age. J. Clin. Endocrinol. Metab. 93, 764-770.
10. Chen, E. Y.; Liao, Y. C.; Smith, D. H.; Barrera-Saldana, H. A.; Gelinas, R. E. and Seeburg, P. H. (1989a) The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 4, 479-497.
11. Chen, T. T.; Kineman, R. D.; Betts, J. G.; Hill, J. B. and Frawley, L. S. (1989b) Relative importance of newly synthesized and stored hormone to basal secretion by growth hormone and prolactin cells. Endocrinology 125, 1904-1909.
12. Chia, D. J.; Subbian, E.; Buck, T. M.; Hwa, V.; Rosenfeld, R. G.; Skach, W. R.; Shinde, U. and Rotwein, P. (2006) Aberrant folding of a mutant Stat5b causes growth hormone insensitivity and proteasomal dysfunction. J. Biol. Chem. 281, 6552-6558.
13. Clemmons, D. R. (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 8, 45-62.
14. Colao, A.; Di Somma, C.; Salerno, M.; Spinelli, L.; Orio, F. and Lombardi, G. (2002) The cardiovascular risk of GH-deficient adolescents. J. Clin. Endocrinol. Metab. 87, 3650-3655.
15. Dastot, F.; Duquesnoy, P.; Sobrier, M. L.; Goossens, M. and Amselem, S. (1998) Evolutionary divergence of the truncated growth hormone receptor isoform in its ability to generate a soluble growth hormone binding protein. Mol. Cell. Endocrinol. 137, 79-84.
16. de Vos, A. M.; Ultsch, M. and Kossiakoff, A. A. (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312.
17. Dimitriadis, G.; Parry-Billings, M.; Leighton, B.; Piva, T.; Dunger, D.; Calder, P.; Bond, J. and Newsholme, E. (1994) Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle. Eur. J. Clin. Invest. 24, 161-165.
18. Dos Santos, C.; Essioux, L.; Teinturier, C.; Tauber, M.; Goffin, V. and Bougneres, P. (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat. Genet. 36, 720-724.
19. Feinberg, M. S.; Scheinowitz, M. and Laron, Z. (2003) Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age. Am. Heart. J. 145, 549-553.
20. Godowski, P. J.; Leung, D. W.; Meacham, L. R.; Galgani, J. P.; Hellmiss, R.; Keret, R.; Rotwein, P. S.; Parks, J. S.; Laron, Z. and Wood, W. I. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc. Natl. Acad. Sci. USA 86, 8083-8087.
21. Goh, E. L.; Pircher, T. J.; Wood, T. J.; Norstedt, G.; Graichen, R. and Lobie, P. E. (1997) Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription. Endocrinology 138, 3207-3215.
22. Gola, M.; Bonadonna, S.; Doga, M. and Giustina, A. (2005) Clinical review: Growth hormone and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 90, 1864-1870.
23. Gouilleux, F.; Pallard, C.; Dusanter-Fourt, I.; Wakao, H.; Haldosen, L. A.; Norstedt, G.; Levy, D. and Groner, B. (1995) Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14, 2005-2013.
24. Herington, A. C.; Ymer, S. I.; Stevenson, J. L. and Roupas, P. (1994) Growth hormone receptor/binding protein: physiology and function. Proc. Soc. Exp. Biol. Med. 206, 238-242.
25. Horan, M.; Newsway, V.; Yasmin; Lewis, M. D.; Easter, T. E.; Rees, D. A.; Mahto, A.; Millar, D. S.; Procter, A. M.; Scanlon, M. F.; Wilkinson, I. B.; Hall, I. P.; Wheatley, A.; Blakey, J.; Bath, P. M.; Cockcroft, J. R.; Krawczak, M. and Cooper, D. N. (2006) Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Hum. Genet. 119, 527-540.
26. Hunziker, E. B.; Wagner, J. and Zapf, J. (1994) Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J. Clin. Invest. 93, 1078-1086.
27. Ihara, K.; Inuo, M.; Kuromaru, R.; Miyako, K.; Kohno, H.; Kinukawa, N. and Hara, T. (2007) The Leu544Ile polymorphism of the growth hormone receptor gene affects the serum cholesterol levels during GH treatment in children with GH deficiency. Clin. Endocrinol. (Oxf.) 67, 212-217.
28. Isaksson, O. G.; Eden, S. and Jansson, J. O. (1985) Mode of action of pituitary growth hormone on target cells. Annu. Rev. Physiol. 47, 483-499.
29. Jensen, R. B.; Vielwerth, S.; Larsen, T.; Greisen, G.; Leffers, H. and Juul, A. (2007) The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. J. Clin. Endocrinol. Metab. 92, 2758-2763.
30. Jorge, A. A.; Marchisotti, F. G.; Montenegro, L. R.; Carvalho, L. R.; Mendonca, B. B. and Arnhold, I. J. (2006) Growth Hormone (GH) Pharmacogenetics: Influence of GH Receptor Exon 3 Retention or Deletion on First-Year Growth Response and Final Height in Patients with Severe GH Deficiency. J. Clin. Endocrinol. Metab. 91, 1076-1080.
31. Jorgensen, J. O.; Blum, W. F.; Moller, N.; Ranke, M. B. and Christiansen, J. S. (1991) Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J. Clin. Endocrinol. Metab. 72, 582-587.
32. Kofoed, E. M.; Hwa, V.; Little, B.; Woods, K. A.; Buckway, C. K.; Tsubaki, J.; Pratt, K. L.; Bezrodnik, L.; Jasper, H.; Tepper, A.; Heinrich, J. J. and Rosenfeld, R. G. (2003) Growth hormone insensitivity associated with a STAT5b mutation. N. Engl. J. Med. 349, 1139-1147.
33. Kohno, H.; Ueyama, N.; Yanai, S.; Ukaji, K. and Honda, S. (1995) Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. J. Pediatr. 126, 953-955.
34. Kuromaru, R.; Kohno, H. and Hara, T. (2002) Changes in adiposity and excess body weight correlate with growth responses but not with decreases in low-density lipoprotein cholesterol levels during GH treatment in GH-deficient children. Clin. Endocrinol. (Oxf.) 56, 799-803.
35. Kuromaru, R.; Kohno, H.; Ueyama, N.; Hassan, H. M.; Honda, S. and Hara, T. (1998) Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. J. Clin. Endocrinol. Metab. 83, 3890-3896.
36. Laron, Z.; Pertzelan, A. and Mannheimer, S. (1966) Genetic pituitary dwarfism with high serum concentation of growth hormone - a new inborn error of metabolism? Isr. J. Med. Sci. 2, 152-155.
37. Laursen, T. (2004) Clinical pharmacological aspects of growth hormone administration. Growth Horm. IGF Res. 14, 16-44.
38. Leonsson, M.; Oscarsson, J.; Bosaeus, I.; Lundgren, B. K.; Johannsson, G.; Wiklund, O. and Bengtsson, B. A. (1999) Growth hormone (GH) therapy in GH-deficient adults influences the response to a dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low density lipoprotein cholesterol levels. J. Clin. Endocrinol. Metab. 84, 1296-1303.
39. Lyuh, E.; Kim, H. J.; Kim, M.; Lee, J. K.; Park, K. S.; Yoo, K. Y.; Lee, K. W. and Ahn, Y. O. (2007) Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells. Growth Horm. IGF Res. 17, 315-322.
40. Markoff, E.; Lee, D. W.; Culler, F. L.; Jones, K. L. and Lewis, U. J. (1986) Release of the 22,000- and the 20,000-dalton variants of growth hormone in vivo and in vitro by human anterior pituitary cells. J. Clin. Endocrinol. Metab. 62, 664-669.
41. Niall, H. D.; Hogan, M. L.; Sauer, R.; Rosenblum, I. Y. and Greenwood, F. C. (1971) Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication. Proc. Natl. Acad. Sci. USA 68, 866-870.
42. Pantel, J.; Grulich-Henn, J.; Bettendorf, M.; Strasburger, C. J.; Heinrich, U. and Amselem, S. (2003) Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. J. Clin. Endocrinol. Metab. 88, 1705-1710.
43. Pantel, J.; Machinis, K.; Sobrier, M. L.; Duquesnoy, P.; Goossens, M. and Amselem, S. (2000) Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J. Biol. Chem. 275, 18664-18669.
44. Pilotta, A.; Mella, P.; Filisetti, M.; Felappi, B.; Prandi, E.; Parrinello, G.; Notarangelo, L. D. and Buzi, F. (2006) Common Polymorphisms of the Growth Hormone (GH) Receptor Do Not Correlate with the Growth Response to Exogenous Recombinant Human GH in GH-Deficient Children. J. Clin. Endocrinol. Metab. 91, 1178-1180.
45. Qiu, X. S.; Tang, N. L.; Yeung, H. Y.; Qiu, Y. and Cheng, J. C. (2007) Genetic association study of growth hormone receptor and idiopathic scoliosis. Clin. Orthop. Relat. Res. 462, 53-58.
46. Rosenfeld, R. G.; Belgorosky, A.; Camacho-Hubner, C.; Savage, M. O.; Wit, J. M. and Hwa, V. (2007) Defects in growth hormone receptor signaling. Trends Endocrinol. Metab. 18, 134-141.
47. Rosenfeld, R. G.; Rosenbloom, A. L. and Guevara-Aguirre, J. (1994) Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr. Rev. 15, 369-390.
48. Rudling, M. and Angelin, B. (1993) Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression. Proc. Natl. Acad. Sci. USA 90, 8851-8855.
49. Rudling, M.; Norstedt, G.; Olivecrona, H.; Reihner, E.; Gustafsson, J. A. and Angelin, B. (1992) Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA 89, 6983-6987.
50. Savage, M. O.; Woods, K. A.; Johnston, L. B.; Postel-Vinay, M. C.; Amselem, S. and Clark, A. J. (1999) Defects of the growth hormone receptor and their clinical implications. Growth. Horm. IGF Res. 9(Suppl A), 57-61.
51. Stachura, M. E.; Tyler, J. M. and Kent, P. G. (1989) Pituitary immediate release pools of growth hormone and prolactin are preferentially refilled by new rather than stored hormone. Endocrinology 125, 444-449.
52. Strawbridge, R. J.; Karvestedt, L.; Li, C.; Efendic, S.; Ostenson, C. G.; Gu, H. F. and Brismar, K. (2007) GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm. IGF Res. 17, 392-398.
53. Takada, D.; Ezura, Y.; Ono, S.; Iino, Y.; Katayama, Y.; Xin, Y.; Wu, L. L.; Larringa-Shum, S.; Stephenson, S. H.; Hunt, S. C.; Hopkins, P. N. and Emi, M. (2003) Growth hormone receptor variant (L526I) modifies plasma HDL cholesterol phenotype in familial hypercholesterolemia: intra-familial association study in an eight-generation hyperlipidemic kindred. Am. J. Med. Genet. A 121, 136-140.
54. Takahashi, Y.; Kaji, H.; Okimura, Y.; Goji, K.; Abe, H. and Chihara, K. (1996) Brief report: short stature caused by a mutant growth hormone. N. Engl. J. Med. 334, 432-436.
55. Takahashi, Y.; Shirono, H.; Arisaka, O.; Takahashi, K.; Yagi, T.; Koga, J.; Kaji, H.; Okimura, Y.; Abe, H.; Tanaka, T. and Chihara, K. (1997) Biologically inactive growth hormone caused by an amino acid substitution. J. Clin. Invest. 100, 1159-1165.
56. Tauber, M.; Ester, W.; Auriol, F.; Molinas, C.; Fauvel, J.; Caliebe, J.; Nugent, T.; Fryklund, L.; Ranke, M. B.; Savage, M. O.; Clark, A. J.; Johnston, L. B. and Hokken-Koelega, A. C. (2007) GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism. Clin. Endocrinol. (Oxf.) 67, 457-461.
57. Thoreau, E.; Petridou, B.; Kelly, P. A.; Djiane, J. and Mornon, J. P. (1991) Structural symmetry of the extracellular domain of the cytokine/ growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Lett. 282, 26-31.
58. Toyoshima, M. T.; Castroneves, L. A.; Costalonga, E. F.; Mendonca, B. B.; Arnhold, I. J. and Jorge, A. A. (2007) Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Clin. Endocrinol. (Oxf.) 67, 500-504.
59. Underwood, L. E.; D'Ercole, A. J.; Clemmons, D. R. and Van Wyk, J. J. (1986) Paracrine functions of somatomedins. Clin. Endocrinol. Metab. 15, 59-77.
60. Vidarsdottir, S.; Walenkamp, M. J.; Pereira, A. M.; Karperien, M.; van Doorn, J.; van Duyvenvoorde, H. A.; White, S.; Breuning, M. H.; Roelfsema, F.; Kruithof, M. F.; van Dissel, J.; Janssen, R.; Wit, J. M. and Romijn, J. A. (2006) Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J. Clin. Endocrinol. Metab. 91, 3482-3485.
61. Wagner, K.; Hemminki, K.; Grzybowska, E.; Bermejo, J. L.; Butkiewicz, D.; Pamula, J.; Pekala, W. and Forsti, A. (2006) Polymorphisms in the growth hormone receptor: A case-control study in breast cancer. Int. J. Cancer 118(11), 2903-2906.
62. Waters, M. J.; Hoang, H. N.; Fairlie, D. P.; Pelekanos, R. A. and Brown, R. J. (2006) New insights into growth hormone action. J. Mol. Endocrinol. 36, 1-7.
63. Zhu, T.; Goh, E. L.; Graichen, R.; Ling, L. and Lobie, P. E. (2001) Signal transduction via the growth hormone receptor. Cell. Signal. 13, 599-616.